These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Enfuvirtide: a new class of antiretroviral therapy for HIV infection. Leao JC; Frezzini C; Porter S Oral Dis; 2004 Nov; 10(6):327-9. PubMed ID: 15533206 [TBL] [Abstract][Full Text] [Related]
3. Initiation of therapy with a subcutaneously administered antiretroviral in treatment-experienced HIV-infected patients: understanding physician and patient perspectives. Horne R; Cooper V; Fisher M AIDS Care; 2008 Oct; 20(9):1029-38. PubMed ID: 18825512 [TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of enfuvirtide for 48 weeks as part of an optimized antiretroviral regimen in pediatric human immunodeficiency virus 1-infected patients. Wiznia A; Church J; Emmanuel P; Eppes S; Rowell L; Evans C; Bertasso A; Pediatr Infect Dis J; 2007 Sep; 26(9):799-805. PubMed ID: 17721374 [TBL] [Abstract][Full Text] [Related]
5. A novel form of amyloid deposited at the site of enfuvirtide injection. Naujokas A; Vidal CI; Mercer SE; Harp J; Kurtin PJ; Fox LP; Thompson MM J Cutan Pathol; 2012 Feb; 39(2):220-1; quiz 219. PubMed ID: 22264247 [No Abstract] [Full Text] [Related]
6. Enfuvirtide: patient acceptance and strategies for managing injection-site reactions. Rice C; Wilantewicz H AIDS Read; 2006 Sep; 16(9):470-4, 490-1. PubMed ID: 17024766 [TBL] [Abstract][Full Text] [Related]
7. Interaction between enfuvirtide, an injectable fusion inhibitor, and niacin in an HIV-infected patient. Oates E; Dzintars K Ann Pharmacother; 2010 Dec; 44(12):2014-7. PubMed ID: 21045170 [TBL] [Abstract][Full Text] [Related]
9. Localized amyloidosis at the site of enfuvirtide injection. Morilla ME; Kocher J; Harmaty M Ann Intern Med; 2009 Oct; 151(7):515-6. PubMed ID: 19805777 [No Abstract] [Full Text] [Related]
10. Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia. Melzer M; Eykyn SJ; Gransden WR; Chinn S Clin Infect Dis; 2003 Dec; 37(11):1453-60. PubMed ID: 14614667 [TBL] [Abstract][Full Text] [Related]
11. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus. Wang JL; Chen SY; Wang JT; Wu GH; Chiang WC; Hsueh PR; Chen YC; Chang SC Clin Infect Dis; 2008 Mar; 46(6):799-806. PubMed ID: 18266610 [TBL] [Abstract][Full Text] [Related]
16. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006. Laupland KB; Ross T; Gregson DB J Infect Dis; 2008 Aug; 198(3):336-43. PubMed ID: 18522502 [TBL] [Abstract][Full Text] [Related]
17. Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Huang SS; Platt R Clin Infect Dis; 2003 Feb; 36(3):281-5. PubMed ID: 12539068 [TBL] [Abstract][Full Text] [Related]
18. Prospective comparison of methicillin-susceptible and methicillin-resistant community-associated Staphylococcus aureus infections in hospitalized patients. Skiest DJ; Brown K; Cooper TW; Hoffman-Roberts H; Mussa HR; Elliott AC J Infect; 2007 May; 54(5):427-34. PubMed ID: 17070598 [TBL] [Abstract][Full Text] [Related]
19. [A case of sepsis caused by methicillin-resistant Staphylococcus aureus aureus (MRSA) following retropubic prostatectomy]. Suwa Y; Sakuramoto T Hinyokika Kiyo; 1994 Nov; 40(11):1017-20. PubMed ID: 7832074 [TBL] [Abstract][Full Text] [Related]
20. Relapse of intravenous drug use triggered by enfuvirtide, a parenteral antiretroviral medication. Avelino-Silva VI; Li HY; Novaes CT AIDS Patient Care STDS; 2012 Feb; 26(2):71-2. PubMed ID: 22148866 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]